Developing Oral Therapeutics for Global Health Security and Cardiometabolic Disease

Arisan Therapeutics is a clinical-stage biotechnology company advancing government-funded infectious disease programs for Ebola and Lassa fever while exploring novel applications of its small-molecule platform in metabolic disease.